Timepolio Asset Management Asset Manager Profile - aVenture Research
Timepolio Asset Management is an asset management firm that focuses on investing in early to mid-stage companies, particularly during Series A and Series B rounds. The firm has demonstrated a keen interest in sectors such as technology and biotechnology, with typical investment sizes ranging from $20 million to $26 million.
Notable portfolio companies include DoubleMe, GenEdit, Point2 Technology, and Rebus Biosystems, each having raised substantial funds under Timepolio's guidance. The firm's investment philosophy centers on fostering innovation and growth within its portfolio. Timepolio offers unique value-add services, leveraging its expertise to support strategic development and operational excellence for its investments.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.